BC-CfE’s proposed expanded access to highly active antiretroviral therapy to curb the growth of the HIV epidemic is endorsed by former Special Envoy to UNAIDS Stephen Lewis, President Bill Clinton and The Economist.
Dr. Montaner received an inaugural Avant Garde award ($2.5 million over 5 years) from the National Institute on Drug Abuse in the USA to support further development of the proposed expanded access to antiretroviral therapy to curb the growth of the HIV epidemic, also known as STOP HIV/AIDS.
Dr. Montaner is appointed President of the International AIDS Society in Mexico City for the term of 2008-2010 and restates the case for Treatment as Prevention.
CLICK FOR NEW HIV-1 RESISTANCE GENOTYPE REPORT NOTICE
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’. For more details and example reports, please click on the button below
